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P1.14-25 Pulmonary Metastasis from Oral Cancer e Who Survive Without Recurrence After Pulmonary Metasectomy?
C. Takasaki, 1 M. Kobayashi, 2 H. Ishibashi, 2 K. Okubo 2 1 Thoracic Surgery, Musashino Red Cross Hospital, Tokyo/JP, 2 Thoracic Surgery, Tokyo Medical and Dental University, Bunkyo-Ku, Tokyo/JP Background: Oral cancer often performs local recurrence or a neck lymph node metastasis, so pulmonary metastasis from oral cancer is very rare and there have been few reports.. The aim of this study was to evaluate the efficacy of surgical resection of oral cancer pulmonary metastases. Method: Between April 2006 and December 2017, 14 patients with oral cancer pulmonary metastases underwent thoracic operations. We considered their clinicopathological features and prognosis. Result: There were ten men and four women with median age of 66.5 years (range, 27-76). All tumors were squamous cell carcinoma. Primary sites were tongue (seven patients), gum (three patients), and the mouth bottom (two patients). Five patients had partial resection and nine patients underwent lobectomy or larger operation. Eight of the nine patients who had lobectomy also had systematic lymph node dissection. Overall survival rate after metastasectomy was 46.9% at five years. Overall survival rate at five years by lobectomy with systematic lymph node dissection tended to have a better prognosis than by partial resection or lobectomy without lymph node dissection(p¼0.08). Among the patients who had systematic lymph node dissection, lymph node metastasis were found in five patients. However, three of the five got long-term survival (more than two years) in spite of the metastasis. Conclusion: For patients with oral cancer pulmonary metastasis, surgical resection especially lobectomy with lymph node desection is recommended. Keywords: metastatic lung cancer, oral cancer P1. Background: Thymic carcinoma is a rare and invasive mediastinal tumor and the optimal treatment is not well defined currently. According to the Clinical report from Japanese Association for Research on the Thymus in 2015, surgical resection is the mainstream of treatment, and the 5-year overall survival was 61%. The patient with complete resection with a 5-year survival of 89%, 68%, 60% for stages I, II and III and IV, respectively. In order to clarify the long-term outcome and prognostic indicators in our facilities, we reviewed our institutional experience with cases of surgical resection for thymic carcinoma. Method: A single-institution retrospective study of patients operated for thymic carcinoma. Between 1998 and 2017, 25 patients with thymic carcinoma underwent surgical resection, and their clinical and pathological data were retrospectively reviewed. Overall survival (OS) rates were compared using a log-rank test and Survival curves were plotted using the KaplaneMeier method. Result: Twenty-five patients underwent surgery for thymic carcinoma. The IASLC/ITMIG thymic epithelial tumors Stage according to the 8 th edition of the TNM classification was I in 9 patients, II in 6, III in 5, IV in 5. A complete resection was achieved in ten patients (40%) that were no recurrence and death in the follow-up period. There was no fetal complication and no postoperative mortality. Adjuvant radiotherapy and/or chemotherapy was offered to 22 patients. The median follow-up period was 37 months. The 5-year overall survival rate for all the patients were 78.2%. Patients who underwent an incomplete resection had a significantly worse survival as compared to those with complete resection in univariate analyses (p < 0.01). Conclusion: Our result indicated that complete resection could impact the overall survival of patients with thymic carcinoma after surgical resection. Keywords: Thymic carcinoma, thymic epithelial tumor P1.14-27 Differentiation Between Each Thymic Epithelial Tumor According to WHO Classification Scheme by Using MDCT Findings Y. Wannasopha, S. Olankitcharoen, S. Kongkarnka, A. Tantraworasin, J. Euathrongchit Radiology, Chiang Mai University, Chiang Mai/TH Background: Thymic epithelial tumors are the uncommon mediastinal tumors but are the most common primary tumors of the anterior mediastinum. Computed tomography (CT) is the imaging modality of choice for assessment in patients suspected thymic epithelial tumor. The objectives of this study were to assess the CT features of various types of thymic epithelial tumors on the basis of the 2004 WHO classification and to identify the specific CT findings for differentiation between each thymic epithelial tumor. Method: A retrospective study reviewed CT findings of 35 patients with thymic epithelial tumors, who underwent surgical resection from January 2010 to April 2017 and had available pre-operative chest CT study. The tumors were reclassified into six types of thymic epithelial tumors (A, AB, B1, B2, B3 and thymic carcinoma) on the basis of the 2004 WHO classification system. The CT findings including the size (longest diameter), margin, shape, presence of focal area of low attenuation of necrosis or cystic change, mediastinal fat invasion, great vessels invasion, degree and pattern of tumor enhancement, presence of tumor calcification and presence of mediastinal lymphadenopathy (short axis diameter more than 10 mm), the presences of pleural effusion, pleural mass, pulmonary nodule, pericardial effusion and extrathoracic metastasis were evaluated. Result: Our study consisted of 20 (57.14%) men and 15 (42.86%) women, age 15-78 years (mean 51.25 years). Pathological proven into 30 thymomas (85.71%) and 5 cases (14.29%) of thymic carcinomas. The 30 thymomas were classified according to WHO classification; type A in 5 (14.29%), type AB in 4 (11.43%), type B1 in 5 (14.29%), type B2 in 9 (25.71%), and type B3 in 7 (20%) patients. The tumor sizes of type A, AB, B1, B2 and B3 thymomas and thymic carcinoma were 6.2±1.97, 8.1±2.17, 4.9±2.47, 6.8±3.04, 4.7±1.87, and 9.6±2.78 cm, respectively. No definite CT manifestation that distinguishes between each different WHO pathological type of thymoma with statistical significance. The tumor dimension > 8 cm, irregular margin, mediastinal fat invasion, great vessel invasion, lymphadenopathy, pericardial effusion and
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